Published Online:
August 8, 2010
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess whether inhaled dry powder mannitol is well tolerated and whether it improves the respiratory function, reduces respiratory exacerbations and improves the quality of life of people with CF.